𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Quality by design: Impact of formulation variables and their interactions on quality attributes of a lyophilized monoclonal antibody

✍ Scribed by David Awotwe-Otoo; Cyrus Agarabi; Geoffrey K. Wu; Elizabeth Casey; Erik Read; Scott Lute; Kurt A. Brorson; Mansoor A. Khan; Rakhi B. Shah

Book ID
118454331
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
836 KB
Volume
438
Category
Article
ISSN
0378-5173

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Examining the impact of excipient materi
Examining the impact of excipient material property variation on drug product quality attributes: A quality-by-design study for a roller compacted, immediate release tablet
✍ JOSEPH Kushner IV; Beth A. Langdon; Jon I. Hiller; Glenn T. Carlson πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 983 KB

A quality-by-design study examining the impact of variability in excipient material properties on the quality attributes of an immediate release tablet was performed. A literature review and risk analysis identified particle size of microcrystalline cellulose (MCC), spray-dried lactose (SDL), and ma

Quality-by-design (QbD): Effects of test
Quality-by-design (QbD): Effects of testing parameters and formulation variables on the segregation tendency of pharmaceutical powder measured by the ASTM D 6940-04 segregation tester
✍ Lin Xie; Huiquan Wu; Meiyu Shen; Larry L. Augsburger; Robbe C. Lyon; Mansoor A. πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 238 KB πŸ‘ 1 views

The objective of this study was to examine the effects of testing parameters and formulation variables on the segregation tendency of pharmaceutical powders measured by the ASTM D 6940-04 segregation tester using design of experiments (DOE) approaches. The test blends consisted of 4% aspirin (ASP) a

Development of a high drug load tablet f
Development of a high drug load tablet formulation based on assessment of powder manufacturability: Moving towards quality by design
✍ Changquan Calvin Sun; Hao Hou; Ping Gao; Chandra Ma; Cesar Medina; Francisco J. πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 170 KB

The development of a robust tablet formulation for a high dose active pharmaceutical ingredient (API) by the trial-and-error approach is challenging. To meet the growing needs of bringing drugs to market faster and with reduced costs, more targeted and efficient development practices are in demand.